The antinociceptive activity of κ- but not δ-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats

https://doi.org/10.1016/S0014-2999(96)00790-XGet rights and content

Abstract

The antinociceptive effect of the preferential μ-opioid receptor agonist morphine (1 mg/kg i.v.), the δ-opioid receptor agonists, DTLET ([d-Thr2,Leu5]enkephalin-Thr) (3 and 6 mg/kg i.v.) and BUBUC ([d-Cys(StBu)2,Leu5]enkephalin-Thr(OtBu) (3 mg/kg i.v.), and the κ-opioid receptor agonist U-69,593 (trans-3,4-dichloro-N-methyl-N-[7-(1-pyrrolidinyl)cyclohexilbenzeneacetamide methanesulfonate) (0.25, 0.5 and 0.75 mg/kg i.v.) was evaluated in mononeuropathic (chronic constriction of the common sciatic nerve) rats. The rats were pretreated s.c. with 10 mg/kg of morphine, or saline, twice daily from day 12 to day 16 after the surgery. In morphine-pretreated rats, the antinociceptive effect of morphine on the vocalization threshold to paw pressure was greatly reduced, as compared to the saline-pretreated group. The antinociceptive effect of DTLET and BUBUC had also disappeared in the morphine-pretreated rats. By contrast, the potent antinociceptive effect of U-69,593 was not affected by the morphine pretreatment. Furthermore, the effect of U-69,593 was reversed by the specific κ-opioid receptor antagonist nor-binaltorphimine (1 and 2 mg/kg i.v.). These results suggest that in mononeuropathic rats, morphine pretreatment results in cross-tolerance to δ- but not to κ-opioid receptor agonists.

References (59)

  • P. Delay-Goyet et al.

    Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptor occupancy

    Pharmacol. Biochem. Behav.

    (1991)
  • J.A. Desmeules et al.

    Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain

    Pain

    (1993)
  • J.A. Desmeules et al.

    The highly selective d agonist BUBU induces analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphine

    Brain Res.

    (1993)
  • J.A. Desmeules et al.

    Influence of the sympathetic nervous system in the development of abnormal pain-related behaviours in a rat model of neuropathic pain

    Neuroscience

    (1995)
  • K. Elliott et al.

    The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor

    N-nitro-l-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids

    Pain

    (1994)
  • B.H. Herman et al.

    Cataleptic effects of dynorphin-(1–13) in rats made tolerant to a mu opiate receptor agonist

    Neuropeptides

    (1981)
  • V. Kayser et al.

    Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats

    Pain

    (1990)
  • V. Kayser et al.

    Repeated low doses of morphine induce a rapid tolerance in arthritic rats but a potentiation of opiate analgesia in normal animals

    Brain Res.

    (1986)
  • V. Kayser et al.

    Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy

    Neuroscience

    (1995)
  • R.C. Kupers et al.

    Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain

    Pain

    (1991)
  • N.M. Lee et al.

    Opiate and peptide interaction: effect of enkephalin on morphine analgesia

    Eur. J. Pharmacol.

    (1980)
  • S.H. Lee et al.

    Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats

    Pain

    (1994)
  • J. Mao et al.

    Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain

    Pain

    (1995)
  • A. Neil et al.

    Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral neuropathy

    Brain Res.

    (1990)
  • I. Nylander et al.

    The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats

    Psychopharmacology

    (1995)
  • P. Ramarao et al.

    Effect of kappa-opioid receptor agonist on morphine analgesia in morphine-naive and morphine-tolerant rats

    Eur. J. Pharmacol.

    (1988)
  • A.K. Rattan et al.

    The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1–13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat

    Brain Res.

    (1992)
  • T. Reisine et al.

    Molecular biology of opioid receptor

    Trends Neurosci.

    (1993)
  • R.E. Rodriguez et al.

    In vivo evidence for spinal delta-opiate receptor-operated antinociception

    Neuropeptides

    (1986)
  • Cited by (24)

    • Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine

      2016, Neuropharmacology
      Citation Excerpt :

      Interestingly, analogs 1, 3 and 4 showed high efficacy delta antagonism at sub-micromolar concentrations. In vivo selectivity was also demonstrated: Fig. 1c shows that antinociceptive effects of all four analogs were significantly blocked by naloxone (1 mg/kg), but not by antagonists for DOR (NTI) or KOR (nor-BNI) at doses (1 mg/kg) known to antagonize selective agonists for those receptors after i.v. injection in the rat (Catheline et al., 1996; Desmeules et al., 1993). The EM analogs showed favorable solubility (40, 20, 20 and 50 mg/ml in water, 15, 15, 12, and 20 mg/ml in saline, and 90, 70, 50, and 50 mg/ml in 20% PEG400/saline for analogs 1–4 respectively), and stable plasma half-life in vitro.

    View all citing articles on Scopus
    View full text